Iconovo AB (Iconovo) is a medical device company that develops, manufactures and supplies in inhalation devices. It offers devices, formulation, analytical testing, documentation and others. The company's products include ICOres, a reservoir-based dry powder inhaler; ICOone is a unit-dose disposable dry powder inhaler; ICOcap, a capsule-based dry powder inhaler; ICOpre is a per-metered dry powder inhaler which carries formulations. The company's products are widely used in the treatment of asthma and respiratory disorders. Iconovo is headquartered in Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Iconovo AB
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Iconovo AB Company Overview
Iconovo AB Company Snapshot
Iconovo AB Pipeline Products and Ongoing Clinical Trials Overview
Iconovo AB – Pipeline Analysis Overview
Iconovo AB - Key Facts
Iconovo AB - Major Products and Services
Iconovo AB Pipeline Products by Development Stage
Iconovo AB Ongoing Clinical Trials by Trial Status
Iconovo AB Pipeline Products Overview
ICOcap
ICOcap Product Overview
ICOone
ICOone Product Overview
ICOone Clinical Trial
ICOone - Oxytocin
ICOone - Oxytocin Product Overview
ICOone - Oxytocin Clinical Trial
ICOpre
ICOpre Product Overview
ICOres
ICOres Product Overview
Multi-Dose Delivery Device
Multi-Dose Delivery Device Product Overview
Iconovo AB - Key Competitors
Iconovo AB - Key Employees
Iconovo AB - Locations And Subsidiaries
Head Office
Recent Developments
Iconovo AB, Recent Developments
May 24, 2024: Iconovo Publishes the Annual Report 2023
May 06, 2024: Iconovo Receives Patent Protection for Icores in China
Apr 16, 2024: Iconovo’s partner Monash University has completed enrollment in a Phase I clinical trial of inhaled oxytocin in ICOone
Mar 11, 2024: Iconovo to Present Positive Data From a Feasibility Study on Nanofitins in ICOone
Feb 07, 2024: Iconovo Signs Additional Contract with Kiox Pharma for Development of a New Inhalable Treatment for Interstitial Lung Disease
Feb 06, 2024: Iconovo Launches Improved Versions of Nasal Icoone Inhalers
Feb 01, 2024: Iconovo Receives Order From Top-10 Pharma Company for Evaluation of Multi-Dose Inhaler
Jan 08, 2024: Iconovo Recruits Gary Pitcairn PhD as Senior Scientific Advisor
Aug 17, 2023: Iconovo Receives Additional Development Contract From Kiox Pharma For New Inhalable Treatment Against Rare Disease
Jun 19, 2023: Iconovo Initiates Feasibility Study With Affilogic for Development of Inhalable Nanofitin-Based Biotherapies
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Iconovo AB Pipeline Products and Ongoing Clinical Trials Overview
Iconovo AB Pipeline Products by Equipment Type
Iconovo AB Pipeline Products by Indication
Iconovo AB Ongoing Clinical Trials by Trial Status
Iconovo AB, Key Facts
Iconovo AB, Major Products and Services
Iconovo AB Number of Pipeline Products by Development Stage
Iconovo AB Pipeline Products Summary by Development Stage
Iconovo AB Ongoing Clinical Trials by Trial Status
Iconovo AB Ongoing Clinical Trials Summary
ICOcap - Product Status
ICOcap - Product Description
ICOone - Product Status
ICOone - Product Description
ICOone - A Feasibility Study with Affilogic for the Development of Inhalable Nanofitin-based Biotherapies
ICOone - Oxytocin - Product Status
ICOone - Oxytocin - Product Description
ICOone - Oxytocin - A Randomized, Single-Center, Partially Single-Blind Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Single and Repeated Doses of Oxytocin Administered via Inhalation or Intravenous or Intramuscular Administration in Healthy Female Participants
ICOpre - Product Status
ICOpre - Product Description
ICOres - Product Status
ICOres - Product Description
Multi-Dose Delivery Device - Product Status
Multi-Dose Delivery Device - Product Description
Iconovo AB, Key Employees
Glossary
List of Figures
Iconovo AB Pipeline Products by Equipment Type
Iconovo AB Pipeline Products by Development Stage
Iconovo AB Ongoing Clinical Trials by Trial Status